IMV Inc IMV-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 06/15/21 EDT
2.86UNCH (UNCH)
52 week range
2.65 - 9.25

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.86
  • 52 Week High9.25
  • 52 Week High Date07/14/20
  • 52 Week Low2.65
  • 52 Week Low Date05/27/21

Key Stats

  • Market Cap162.44M
  • Shares Out67.71M
  • 10 Day Average Volume39,606.18
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-26.48

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.86
  • 52 Week High9.25
  • 52 Week High Date07/14/20
  • 52 Week Low2.65
  • 52 Week Low Date05/27/21
  • Market Cap162.44M
  • Shares Out67.71M
  • 10 Day Average Volume39,606.18
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-26.48

RATIOS/PROFITABILITY

  • EPS (TTM)-0.50
  • P/E (TTM)-5.73
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IMV Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
IMV Inc. is a clinical stage biopharmaceutical company focused on developing cancer immunotherapies and vaccines against infectious diseases, including coronavirus disease 2019 (COVID-19). The Company develops cancer-targeted immunotherapies and vaccines based on the Company’s platform, DPX. The Company’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy that combines the platform with a cancer target: survivin. Its T cell therapy is evaluated in phase II...
Andrew Sheldon
Chairman
Frederic Ors
Chief Executive Officer
Pierre Labbe CPA
Chief Financial Officer
Address
130 Eileen Stubbs Ave Suite 19
Dartmouth, NS
B3B 2C4
Canada

Top Peers

SYMBOLLASTCHG%CHG
DMAC
DiaMedica Therapeutics Inc
8.63-0.54-5.89%
ONC
MDNA
Medicenna Therapeutics Corp
3.76-0.12-3.09%
CRDL
Cardiol Therapeutics Inc
3.06UNCHUNCH
HBP
Huttig Building Products Inc
6.07+0.19+3.23%